AU2021107564A4 — Methods for photodynamic therapy
Assigned to Sun Pharmaceutical Industries Inc · Expires 2022-01-06 · 4y expired
What this patent protects
The present invention relates to a method of photodynamic treatment of actinic keratosis, comprising applying 5-aminolevulinic acid to an actinic keratotic lesion on the stratum corneum of an upper extremity, the 5-aminolevulinic acid being in a composition having a gel form; a…
USPTO Abstract
The present invention relates to a method of photodynamic treatment of actinic keratosis, comprising applying 5-aminolevulinic acid to an actinic keratotic lesion on the stratum corneum of an upper extremity, the 5-aminolevulinic acid being in a composition having a gel form; and reducing evaporation from a portion of the stratum corneum including an area where the lesion is present using an occlusive dressing. 17587577_1 (GHMatters) P110419.AU.3
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.